Clinical Trial Update: Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

A Phase Ib trial evaluating Rocbrutinib in combination with R-CHOP for newly diagnosed B-cell Non-Hodgkin Lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Rocbrutinib (rocbrutinib)

Snippet

Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Conditions: B-cell Non-Hodgkin Lymphoma | Phase 1 | Status: RECRUITING